Manufacturing processes of plasma-derived products remove prions

被引：0
|
作者：
Groener, A. [1 ]
Schaefer, W. [1 ]
机构：
[1] CSL Behring, Virol, Marburg, Germany
来源：
JOURNAL OF THROMBOSIS AND HAEMOSTASIS | 2009年 / 7卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
PP-MO-557
引用
收藏
页码：508 / 508
页数：1
相关论文
共 50 条
  • [11] Viral risks of plasma-derived medicinal products
    Janssen, M. P.
    Cuijpers, T. M.
    Van der Poel, C. L.
    Over, J.
    TRANSFUSION, 2006, 46 (09) : 108A - 108A
  • [12] Viral risks of plasma-derived medicinal products
    Janssen, M. P.
    van der Poel, C. L.
    van Hout, B. A.
    Over, J.
    Cuijpers, H. T. M.
    VOX SANGUINIS, 2006, 91 : 5 - 5
  • [13] Shortage of plasma-derived products: a looming crisis?
    Li Covington, Mischa
    Voma, Chesinta
    Stowell, Sean R.
    BLOOD, 2022, 139 (21) : 3222 - 3225
  • [14] Manufacture of plasma-derived products in France and measures to prevent the risk of vCJD transmission: Precautionary measures and efficacy of manufacturing processes in prion removal
    Flan, Benoit
    Arrabal, Samuel
    TRANSFUSION CLINIQUE ET BIOLOGIQUE, 2007, 14 (01) : 51 - 62
  • [15] Plasma-derived medicinal products: demand and clinical use
    Grazzini, Giuliano
    Mannucci, Pier Mannuccio
    Oleari, Fabrizio
    BLOOD TRANSFUSION, 2013, 11 : S2 - S5
  • [16] Plasma-derived products: dosage guidelines for paediatric use
    Esnault, M.
    Prot-Labarthe, S.
    Bourdon, O.
    Hurtaud, M. -F.
    Rouault, A.
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2016, 38 (02) : 513 - 513
  • [17] Infusion reactions from human plasma-derived products
    Ko, Hon-Sum
    CLINICAL IMMUNOLOGY, 2007, 123 : S79 - S80
  • [18] Viral safety evaluation of plasma-derived therapeutic products
    Farshid, M
    PDA/EMEA EUROPEAN VIRUS SAFETY FORUM, 2004, 118 : 11 - 15
  • [19] Virus inactivation during the freeze-drying processes as used for the manufacture of plasma-derived medicinal products
    Unger, Ulrike
    Poelsler, Gerhard
    Modrof, Jens
    Kreil, Thomas R.
    TRANSFUSION, 2009, 49 (09) : 1924 - 1930
  • [20] FDA to propose tracking, notification system for plasma-derived products
    不详
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 1999, 56 (22) : 2274 - 2274
12345